What Proportion of BRCA–Associated Breast Cancer Is Human Epidermal Growth Factor 2–Low and Eligible for Additional Targeted Therapy?

Emily Forester, Aakash Belsare, Dong Won Kim, Kristen Whitaker, Elias Obeid, Lori J. Goldstein, Richard J. Bleicher, Mary B. Daly, Austin D. Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'What Proportion of BRCA–Associated Breast Cancer Is Human Epidermal Growth Factor 2–Low and Eligible for Additional Targeted Therapy?'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry